4 options
Stem cells and regenerative medicine Volume VII, Diseases and therapy / Philippe Taupin.
- Format:
- Book
- Author/Creator:
- Taupin, Philippe.
- Series:
- Stem Cells and Regenerative Medicine
- Stem cells and regenerative medicine, 2159-8754 ; v. 7
- Language:
- English
- Subjects (All):
- Stem cells.
- Regenerative medicine.
- Physical Description:
- 1 online resource (238 p.)
- Edition:
- 1st ed.
- Place of Publication:
- New York : Nova Science Publishers, Inc., 2012.
- Language Note:
- English
- Summary:
- Stem cells are the building blocks of the body and can develop into any of the cells that make up our bodies. Stem cells carry a lot of hope for the treatment of a broad range of diseases and injuries, spanning from cancers, diabetes, genetic diseases, graft-versus-host disease, eye, heart and liver diseases, inflammatory and autoimmune disorders, to neurological diseases and injuries, particularly neurodegenerative diseases, like Alzheimer's and Parkinson's disease and many others. This book provides an overview and in-depth analysis of recent developments in stem cell research and therapy. It is composed of recently published review articles that went through a peer-review process.
- Contents:
- Intro
- STEM CELLS AND REGENERATIVE MEDICINE VOLUME VII DISEASES AND THERAPY
- Contents
- Introduction Adult Neurogenesis and Neural Stem Cells: Developmental and Therapeutic Potential
- Acknowledgments
- Chapter I Enhanced Neurogenesis following Neurological Disease
- Abstract
- Adult Neurogenesis in Alzheimer's Disease and in Neurodegenerative Diseases of the Brain
- Huntington's Disease
- Parkinson's Disease
- Adult Neurogenesis in Epilepsy
- Function of the Newly Generated Neuronal Cells in Neurological Diseases
- Therapy
- Stimulation of Endogenous Neural Progenitor Cells
- Transplantation
- Conclusions
- References
- Chapter II Alzheimer's Disease: Increased Neurogenesis and Possible Disease Mechanisms Related to Neurogenesis
- Etiology and Pathology of Alzheimer' s Disease
- Amyloid Plaques and Neurofibrillary Tangles
- Genetic Factors and Mutations
- Aneuploidy
- Enhanced Neurogenesis
- Possible Mechanisms Related to Adult Neurogenesis
- Aneuploidy in AD Patients
- Aneuploidy for Chromosome 21 and Amyloid Deposits
- Aneuploidy for Chromosome 17 and Neurofibrillary Tangles Formation
- Aneuploidy for Chromosomes 1, 14 and 19 and Pathogenesis of AD
- Aneuploidy and Adult Neurogenesis
- Factors Promoting Aneuploidy in Alzheimer's Disease
- Hyperphosphorylation of Tau Protein
- Mutation in PSEN1
- Modulation of Adult Neurogenesis
- Oxidative Stress
- Conclusion and Perspectives
- Chapter III Neurogenesis, NSCs, Pathogenesis and Therapies for Alzheimer's Disease
- Abbreviations
- Introduction
- Adult Neurogenesis and Neural Stem Cells
- Neurogenesis in the Adult Brain of Mammals
- Neural Progenitor and Stem Cells In Vitro.
- Modulation of Adult Neurogenesis In Vivo
- Cellular Therapy
- Alzheimer's Disease
- A Senile Dementia and Neurodegenerative Disease
- Genetic Mutations and Risks Factors in Alzheimer's Disease
- Aneuploidy in Region of Neurodegeneration
- Adult Neurogenesis and the Pathogenesis of Alzheimer's Disease
- Neurogenesis in Alzheimer's Disease
- Aneuploid Newly Generated Neuronal Cells in the Adult Brain with Alzheimer's Disease
- Novel Drug Targets for Alzheimer's Disease
- Newly Generated Neuronal Cells of the Adult Brain
- Aneuploid Newly Generated Neuronal Cells of the Adult Brain
- Summary and Perspectives
- Chapter IV Adult Neurogenesis and Drug Therapy*
- Neurogenesis in the Adult Mammalian Brain
- Neurogenesis and Neurological Diseases, Disorders and Injuries
- Neurogenesis in Neurodegenerative Diseases and Disorders
- Neurogenesis and Injuries
- Discussion
- Stimulation of Neurogenesis
- Drug Therapy
- Conclusion
- Chapter V Neurogenic Factors Are Targets in Depression
- Adult Neurogenesis and Depression
- Adult Neurogenesis and the Pharmacology of Depression
- The Hippocampus and Depression
- Limitations of Paradigms and Models to Study Adult Neurogenesis and Depression
- Chapter VI Pharmacology of Adult Neurogenesis: Compensatory and Regenerative Processes
- Pharmacology of Adult Neurogenesis in Alzheimer's Disease
- Alzheimer's Disease and Drug Therapy
- Adult Neurogenesis and Alzheimer's Disease Drugs
- Pharmacology of Adult Neurogenesis in Depression
- Depression and Antidepressants
- Adult Neurogenesis and Antidepressants
- Discussion.
- Drug Therapy: Compensatory Processes
- Adult Neurogenesis in Neurological Diseases and Disorders: Regenerative Processes
- Adult Neural Stem Cells and Regenerative Medicine
- Chapter VII Adult Neurogenesis, Neuroinflammation, and Therapeutic Potential of Adult Neural Stem Cells
- Neurogenesis and Neural Stem Cells in the Adult CNS
- Adult Neurogenesis in Neurological Diseases and Disorders
- Depression
- Epilepsy
- Therapeutic Potential of Adult Neural Stem Cells
- Stimulation of Neural Progenitor or Stem Cells of the Adult CNS
- Transplantation of Neural Progenitor and Stem Cells of the Adult CNS
- Neuroinflammation and the Therapeutic Potential of Adult NSCs
- Neuroin ammation in Neurological Diseases and Injuries
- Neuroin ammation in Adult Neurogenesis
- Neuroin ammation and Neural Progenitor and Stem Cell Transplantation
- Limitations and Pitfalls of BrdU Labelling for Studying Neurogenesis
- Conclusions and Perspectives
- Chapter VIII A Dual Activity of ROS and Oxidative Stress on Adult Neurogenesis and Alzheimer's Disease*
- Alzheimer's Disease Is Caused by Excessive Rate of Genome Damage
- Enhanced Neurogenesis in Alzheimer's Disease
- Oxidative Stress Contributes to the Pathogenesis of Alzheimer's Disease
- A Dual Activity of ROS and Oxidative Stress on Adult Neurogenesis and on the Pathogenesis of Alzheimer's Disease
- ROS and Oxidative Stress Control the Cell Cycle and Genomic Stability
- Concluding Remarks
- Chapter IX Adult Neurogenesis and Neural Stem Cells as a Model for the Discovery and Development of Novel Drugs
- Introduction.
- Adult Neurogenesis and Drugs to Treat Neurological Diseases and Disorders
- Adult Neurogenesis and NSCs Are Targets of Drugs Used for Treating Neurological Diseases and Disorders
- Neurogenic Drugs to Reverse or Compensate Deficits and Impairments Associated with the Hippocampus
- Expert Opinion
- Adult NSCs: A Promising Model to Discover and Develop Neurogenic Drugs
- Limitations and Pitfalls of Adult NSCs for Discovering and Developing Neurogenic Drugs
- Declaration of Interest
- Bibliography
- Chapter X Neurogenic Drugs and Compounds*
- Recent patents on Compounds and Drugs Modulating Neurogenesis in the Adult Brain Nootropic Agents
- The Activity of 15 Compounds and their Derivatives
- Apigenin and Related Compounds
- Current and Future Developments
- Conflict of Interest
- Chapter XI Very Small Embryonic-like Stem Cells for Regenerative Medicine*
- Background
- Methods
- Results
- Chemistry
- Biology and Action
- Chapter XII Transplantation of Cord Blood Stem Cells for Treating Hematologic Diseases and Strategies to Improve Engraftment
- Executive Summary
- HSCs and Cord Blood Stem Cells
- Selectins and the Homing of HSCs
- P- and E-selectins and Selectin Glycoprotein Ligands
- Homing of Hematopoietic Progenitor and Stem Cells of the BM and CB
- Transplantation of Cord Blood Stem Cells for the Treatment of Hematologic Diseases
- Total Nucleated Cell Count and Age of Patients
- Early Infections and Delayed Engraftment
- Graft-versus-Host Disease
- Strategies to Improve the Outcome of CB Transplantation for the Treatment of Hematologic Diseases.
- Direct Delivery of Cord Blood Stem Cells to the Bone Marrow
- Transplantation of Double Cord Blood Units
- Fucosylation of Selectin Glycoprotein Ligands Ex Vivo
- Expansion and Propagation of Cord Blood Stem Cells In Vitro
- Future Perspectives
- Financial and Competing Interests Disclosure
- Chapter XIII Transplantation of Two Populations of Stem Cells to Improve Engraftment*
- Transplant
- Chapter XIV Ex Vivo Fucosylation of Stem Cells to Improve Engraftment*
- Objective
- In Vivo and In Vitro Studies
- Fucosyltransferases
- Chapter XV Thirteen Compounds Promoting Oligodendrocyte Progenitor Cell Differentiation and Remyelination for Treating Multiple Sclerosis
- Chemistry and Synthesis
- Culture of Oligodendrocyte Progenitor Cells
- Cerebellar Organotypic Cultures and Lysolecithin Demyelination
- Zebrafish Model
- Cuprizone-mediated Demyelination Mouse Model
- Other Assays
- Drug Screenings
- Primary Screening
- Secondary Screening
- Chapter XVI Antibodies against CD20 (Rituximab) for Treating Multiple Sclerosis
- Acknowledgments.
- Bibliography.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references and index.
- ISBN:
- 1-62081-121-9
- OCLC:
- 923665378
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.